Who owns Franklin Templeton Etf Tr genomic adv etf?
- Ticker: HELX
- CUSIP Number: 35473p520
Tip: Access positions for across all investors
Analyze quarterly positions in Franklin Templeton Etf Tr genomic adv etf with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Franklin Templeton Etf Tr genomic adv etf stock
Who bought or sold Franklin Templeton Etf Tr genomic adv etf this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 38k | $1.2M | 100% | Mar 2026 |
|
| LPL Financial | 6.7k | $222k | -40% | Mar 2026 |
|
| Advisor Group Holdings | 3.1k | $114k | 0% | Dec 2025 |
|
| Franklin Resources | 2.7k | $88k | 100% | Mar 2026 |
|
| Harbour Investments | 1.7k | $55k | 9% | Mar 2026 |
|
| UBS Group | 89.00 | $2.9k | 102% | Mar 2026 |
|
| Western Wealth Management | 10.00 | $331.000000 | 100% | Mar 2026 |
|
Who sold out of Franklin Templeton Etf Tr genomic adv etf?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Kestra Advisory Services | Dec 2025 | 1.1k | $39k |